Shopping Cart 0
Cart Subtotal
USD 0

Global CAR-T Cell Therapy Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 3400

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 6200

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 6200

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 6200

Details

The CAR-T Cell Therapy market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global CAR-T Cell Therapy market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global CAR-T Cell Therapy market. The report focuses on well-known providers in the global CAR-T Cell Therapy industry, market segments, competition, and the macro environment.
 
Under COVID-19 Outbreak, how the CAR-T Cell Therapy Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
 
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
 
Key players in the global CAR-T Cell Therapy market covered in Chapter 4:
Novartis International AG
Celgene Corporation
Kite Pharma, Inc. (Gilead Sciences, Inc.)
Aurora Biopharma Inc
Mustang Bio, Inc.
Legend Biotech (Genscript Biotech Corporation)
CARsgen Therapeutics, Ltd.
Sorrento Therapeutics Inc.
Pfizer, Inc.
 
In Chapter 11 and 13.3, on the basis of types, the CAR-T Cell Therapy market from 2015 to 2026 is primarily split into:
CD 19
CD 20
GD2
CD22
CD30
CD33
HER1
HER2
Meso
EGFRvlll
 
In Chapter 12 and 13.4, on the basis of applications, the CAR-T Cell Therapy market from 2015 to 2026 covers:
Acute Lymphoblastic Leukemia (ALL)
Chronic lymphocytic leukemia (CLL)
Non-Hodgkin lymphoma
Acute myeloid leukemia (AML)
Neuroblastoma
Multiple myeloma (MM)
Others
 
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
 
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
READ MORE

Table Of Content

Scope

Table of Content

 

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global CAR-T Cell Therapy Market Share by Type (2020-2026)

1.5.2 CD 19

1.5.3 CD 20

1.5.4 GD2

1.5.5 CD22

1.5.6 CD30

1.5.7 CD33

1.5.8 HER1

1.5.9 HER2

1.5.10 Meso

1.5.11 EGFRvlll

1.6 Market by Application

1.6.1 Global CAR-T Cell Therapy Market Share by Application (2020-2026)

1.6.2 Acute Lymphoblastic Leukemia (ALL)

1.6.3 Chronic lymphocytic leukemia (CLL)

1.6.4 Non-Hodgkin lymphoma

1.6.5 Acute myeloid leukemia (AML)

1.6.6 Neuroblastoma

1.6.7 Multiple myeloma (MM)

1.6.8 Others

1.7 CAR-T Cell Therapy Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on CAR-T Cell Therapy Industry Development

 

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 PorteraEUR s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

 

3 Value Chain of CAR-T Cell Therapy Market

3.1 Value Chain Status

3.2 CAR-T Cell Therapy Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of CAR-T Cell Therapy

3.2.3 Labor Cost of CAR-T Cell Therapy

3.2.3.1 Labor Cost of CAR-T Cell Therapy Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

 

4 Players Profiles

4.1 Novartis International AG

4.1.1 Novartis International AG Basic Information

4.1.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.1.3 Novartis International AG CAR-T Cell Therapy Market Performance (2015-2020)

4.1.4 Novartis International AG Business Overview

4.2 Celgene Corporation

4.2.1 Celgene Corporation Basic Information

4.2.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.2.3 Celgene Corporation CAR-T Cell Therapy Market Performance (2015-2020)

4.2.4 Celgene Corporation Business Overview

4.3 Kite Pharma, Inc. (Gilead Sciences, Inc.)

4.3.1 Kite Pharma, Inc. (Gilead Sciences, Inc.) Basic Information

4.3.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.3.3 Kite Pharma, Inc. (Gilead Sciences, Inc.) CAR-T Cell Therapy Market Performance (2015-2020)

4.3.4 Kite Pharma, Inc. (Gilead Sciences, Inc.) Business Overview

4.4 Aurora Biopharma Inc

4.4.1 Aurora Biopharma Inc Basic Information

4.4.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.4.3 Aurora Biopharma Inc CAR-T Cell Therapy Market Performance (2015-2020)

4.4.4 Aurora Biopharma Inc Business Overview

4.5 Mustang Bio, Inc.

4.5.1 Mustang Bio, Inc. Basic Information

4.5.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.5.3 Mustang Bio, Inc. CAR-T Cell Therapy Market Performance (2015-2020)

4.5.4 Mustang Bio, Inc. Business Overview

4.6 Legend Biotech (Genscript Biotech Corporation)

4.6.1 Legend Biotech (Genscript Biotech Corporation) Basic Information

4.6.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.6.3 Legend Biotech (Genscript Biotech Corporation) CAR-T Cell Therapy Market Performance (2015-2020)

4.6.4 Legend Biotech (Genscript Biotech Corporation) Business Overview

4.7 CARsgen Therapeutics, Ltd.

4.7.1 CARsgen Therapeutics, Ltd. Basic Information

4.7.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.7.3 CARsgen Therapeutics, Ltd. CAR-T Cell Therapy Market Performance (2015-2020)

4.7.4 CARsgen Therapeutics, Ltd. Business Overview

4.8 Sorrento Therapeutics Inc.

4.8.1 Sorrento Therapeutics Inc. Basic Information

4.8.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.8.3 Sorrento Therapeutics Inc. CAR-T Cell Therapy Market Performance (2015-2020)

4.8.4 Sorrento Therapeutics Inc. Business Overview

4.9 Pfizer, Inc.

4.9.1 Pfizer, Inc. Basic Information

4.9.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.9.3 Pfizer, Inc. CAR-T Cell Therapy Market Performance (2015-2020)

4.9.4 Pfizer, Inc. Business Overview

 

5 Global CAR-T Cell Therapy Market Analysis by Regions

5.1 Global CAR-T Cell Therapy Sales, Revenue and Market Share by Regions

5.1.1 Global CAR-T Cell Therapy Sales by Regions (2015-2020)

5.1.2 Global CAR-T Cell Therapy Revenue by Regions (2015-2020)

5.2 North America CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

5.3 Europe CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

5.6 South America CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

 

6 North America CAR-T Cell Therapy Market Analysis by Countries

6.1 North America CAR-T Cell Therapy Sales, Revenue and Market Share by Countries

6.1.1 North America CAR-T Cell Therapy Sales by Countries (2015-2020)

6.1.2 North America CAR-T Cell Therapy Revenue by Countries (2015-2020)

6.1.3 North America CAR-T Cell Therapy Market Under COVID-19

6.2 United States CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

6.2.1 United States CAR-T Cell Therapy Market Under COVID-19

6.3 Canada CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

6.4 Mexico CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

 

7 Europe CAR-T Cell Therapy Market Analysis by Countries

7.1 Europe CAR-T Cell Therapy Sales, Revenue and Market Share by Countries

7.1.1 Europe CAR-T Cell Therapy Sales by Countries (2015-2020)

7.1.2 Europe CAR-T Cell Therapy Revenue by Countries (2015-2020)

7.1.3 Europe CAR-T Cell Therapy Market Under COVID-19

7.2 Germany CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

7.2.1 Germany CAR-T Cell Therapy Market Under COVID-19

7.3 UK CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

7.3.1 UK CAR-T Cell Therapy Market Under COVID-19

7.4 France CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

7.4.1 France CAR-T Cell Therapy Market Under COVID-19

7.5 Italy CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

7.5.1 Italy CAR-T Cell Therapy Market Under COVID-19

7.6 Spain CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

7.6.1 Spain CAR-T Cell Therapy Market Under COVID-19

7.7 Russia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

7.7.1 Russia CAR-T Cell Therapy Market Under COVID-19

 

8 Asia-Pacific CAR-T Cell Therapy Market Analysis by Countries

8.1 Asia-Pacific CAR-T Cell Therapy Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific CAR-T Cell Therapy Sales by Countries (2015-2020)

8.1.2 Asia-Pacific CAR-T Cell Therapy Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific CAR-T Cell Therapy Market Under COVID-19

8.2 China CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

8.2.1 China CAR-T Cell Therapy Market Under COVID-19

8.3 Japan CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

8.3.1 Japan CAR-T Cell Therapy Market Under COVID-19

8.4 South Korea CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

8.4.1 South Korea CAR-T Cell Therapy Market Under COVID-19

8.5 Australia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

8.6 India CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

8.6.1 India CAR-T Cell Therapy Market Under COVID-19

8.7 Southeast Asia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia CAR-T Cell Therapy Market Under COVID-19

 

9 Middle East and Africa CAR-T Cell Therapy Market Analysis by Countries

9.1 Middle East and Africa CAR-T Cell Therapy Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa CAR-T Cell Therapy Sales by Countries (2015-2020)

9.1.2 Middle East and Africa CAR-T Cell Therapy Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa CAR-T Cell Therapy Market Under COVID-19

9.2 Saudi Arabia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

9.3 UAE CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

9.4 Egypt CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

9.5 Nigeria CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

9.6 South Africa CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

 

10 South America CAR-T Cell Therapy Market Analysis by Countries

10.1 South America CAR-T Cell Therapy Sales, Revenue and Market Share by Countries

10.1.1 South America CAR-T Cell Therapy Sales by Countries (2015-2020)

10.1.2 South America CAR-T Cell Therapy Revenue by Countries (2015-2020)

10.1.3 South America CAR-T Cell Therapy Market Under COVID-19

10.2 Brazil CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

10.2.1 Brazil CAR-T Cell Therapy Market Under COVID-19

10.3 Argentina CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

10.4 Columbia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

10.5 Chile CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

 

11 Global CAR-T Cell Therapy Market Segment by Types

11.1 Global CAR-T Cell Therapy Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global CAR-T Cell Therapy Sales and Market Share by Types (2015-2020)

11.1.2 Global CAR-T Cell Therapy Revenue and Market Share by Types (2015-2020)

11.2 CD 19 Sales and Price (2015-2020)

11.3 CD 20 Sales and Price (2015-2020)

11.4 GD2 Sales and Price (2015-2020)

11.5 CD22 Sales and Price (2015-2020)

11.6 CD30 Sales and Price (2015-2020)

11.7 CD33 Sales and Price (2015-2020)

11.8 HER1 Sales and Price (2015-2020)

11.9 HER2 Sales and Price (2015-2020)

11.10 Meso Sales and Price (2015-2020)

11.11 EGFRvlll Sales and Price (2015-2020)

 

12 Global CAR-T Cell Therapy Market Segment by Applications

12.1 Global CAR-T Cell Therapy Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global CAR-T Cell Therapy Sales and Market Share by Applications (2015-2020)

12.1.2 Global CAR-T Cell Therapy Revenue and Market Share by Applications (2015-2020)

12.2 Acute Lymphoblastic Leukemia (ALL) Sales, Revenue and Growth Rate (2015-2020)

12.3 Chronic lymphocytic leukemia (CLL) Sales, Revenue and Growth Rate (2015-2020)

12.4 Non-Hodgkin lymphoma Sales, Revenue and Growth Rate (2015-2020)

12.5 Acute myeloid leukemia (AML) Sales, Revenue and Growth Rate (2015-2020)

12.6 Neuroblastoma Sales, Revenue and Growth Rate (2015-2020)

12.7 Multiple myeloma (MM) Sales, Revenue and Growth Rate (2015-2020)

12.8 Others Sales, Revenue and Growth Rate (2015-2020)

 

13 CAR-T Cell Therapy Market Forecast by Regions (2020-2026)

13.1 Global CAR-T Cell Therapy Sales, Revenue and Growth Rate (2020-2026)

13.2 CAR-T Cell Therapy Market Forecast by Regions (2020-2026)

13.2.1 North America CAR-T Cell Therapy Market Forecast (2020-2026)

13.2.2 Europe CAR-T Cell Therapy Market Forecast (2020-2026)

13.2.3 Asia-Pacific CAR-T Cell Therapy Market Forecast (2020-2026)

13.2.4 Middle East and Africa CAR-T Cell Therapy Market Forecast (2020-2026)

13.2.5 South America CAR-T Cell Therapy Market Forecast (2020-2026)

13.3 CAR-T Cell Therapy Market Forecast by Types (2020-2026)

13.4 CAR-T Cell Therapy Market Forecast by Applications (2020-2026)

13.5 CAR-T Cell Therapy Market Forecast Under COVID-19

 

14 Appendix

14.1 Methodology

14.2 Research Data Source

 


List Of Figure

List of Tables and Figures

Table Global CAR-T Cell Therapy Market Size Growth Rate by Type (2020-2026)

Figure Global CAR-T Cell Therapy Market Share by Type in 2019 & 2026

Figure CD 19 Features

Figure CD 20 Features

Figure GD2 Features

Figure CD22 Features

Figure CD30 Features

Figure CD33 Features

Figure HER1 Features

Figure HER2 Features

Figure Meso Features

Figure EGFRvlll Features

Table Global CAR-T Cell Therapy Market Size Growth by Application (2020-2026)

Figure Global CAR-T Cell Therapy Market Share by Application in 2019 & 2026

Figure Acute Lymphoblastic Leukemia (ALL) Description

Figure Chronic lymphocytic leukemia (CLL) Description

Figure Non-Hodgkin lymphoma Description

Figure Acute myeloid leukemia (AML) Description

Figure Neuroblastoma Description

Figure Multiple myeloma (MM) Description

Figure Others Description

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on CAR-T Cell Therapy Industry Development

Table SWOT Analysis

Figure Porter's Five Forces Analysis

Figure Global CAR-T Cell Therapy Market Size and Growth Rate 2015-2026

Table Industry News

Table Industry Policies

Figure Value Chain Status of CAR-T Cell Therapy

Figure Production Process of CAR-T Cell Therapy

Figure Manufacturing Cost Structure of CAR-T Cell Therapy

Figure Major Company Analysis (by Business Distribution Base, by Product Type)

Table Downstream Major Customer Analysis (by Region)

Table Novartis International AG Profile

Table Novartis International AG Production, Value, Price, Gross Margin 2015-2020

Table Celgene Corporation Profile

Table Celgene Corporation Production, Value, Price, Gross Margin 2015-2020

Table Kite Pharma, Inc. (Gilead Sciences, Inc.) Profile

Table Kite Pharma, Inc. (Gilead Sciences, Inc.) Production, Value, Price, Gross Margin 2015-2020

Table Aurora Biopharma Inc Profile

Table Aurora Biopharma Inc Production, Value, Price, Gross Margin 2015-2020

Table Mustang Bio, Inc. Profile

Table Mustang Bio, Inc. Production, Value, Price, Gross Margin 2015-2020

Table Legend Biotech (Genscript Biotech Corporation) Profile

Table Legend Biotech (Genscript Biotech Corporation) Production, Value, Price, Gross Margin 2015-2020

Table CARsgen Therapeutics, Ltd. Profile

Table CARsgen Therapeutics, Ltd. Production, Value, Price, Gross Margin 2015-2020

Table Sorrento Therapeutics Inc. Profile

Table Sorrento Therapeutics Inc. Production, Value, Price, Gross Margin 2015-2020

Table Pfizer, Inc. Profile

Table Pfizer, Inc. Production, Value, Price, Gross Margin 2015-2020

Figure Global CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Global CAR-T Cell Therapy Revenue (USD ) and Growth (2015-2020)

Table Global CAR-T Cell Therapy Sales by Regions (2015-2020)

Table Global CAR-T Cell Therapy Sales Market Share by Regions (2015-2020)

Table Global CAR-T Cell Therapy Revenue (USD ) by Regions (2015-2020)

Table Global CAR-T Cell Therapy Revenue Market Share by Regions (2015-2020)

Table Global CAR-T Cell Therapy Revenue Market Share by Regions in 2015

Table Global CAR-T Cell Therapy Revenue Market Share by Regions in 2019

Figure North America CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Europe CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Asia-Pacific CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Middle East and Africa CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure South America CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure North America CAR-T Cell Therapy Revenue (USD ) and Growth (2015-2020)

Table North America CAR-T Cell Therapy Sales by Countries (2015-2020)

Table North America CAR-T Cell Therapy Sales Market Share by Countries (2015-2020)

Figure North America CAR-T Cell Therapy Sales Market Share by Countries in 2015

Figure North America CAR-T Cell Therapy Sales Market Share by Countries in 2019

Table North America CAR-T Cell Therapy Revenue (USD ) by Countries (2015-2020)

Table North America CAR-T Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure North America CAR-T Cell Therapy Revenue Market Share by Countries in 2015

Figure North America CAR-T Cell Therapy Revenue Market Share by Countries in 2019

Figure United States CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Canada CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Mexico CAR-T Cell Therapy Sales and Growth (2015-2020)

Figure Europe CAR-T Cell Therapy Revenue (USD ) Growth (2015-2020)

Table Europe CAR-T Cell Therapy Sales by Countries (2015-2020)

Table Europe CAR-T Cell Therapy Sales Market Share by Countries (2015-2020)

Figure Europe CAR-T Cell Therapy Sales Market Share by Countries in 2015

Figure Europe CAR-T Cell Therapy Sales Market Share by Countries in 2019

Table Europe CAR-T Cell Therapy Revenue (USD ) by Countries (2015-2020)

Table Europe CAR-T Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure Europe CAR-T Cell Therapy Revenue Market Share by Countries in 2015

Figure Europe CAR-T Cell Therapy Revenue Market Share by Countries in 2019

Figure Germany CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure UK CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure France CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Italy CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Spain CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Russia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Asia-Pacific CAR-T Cell Therapy Revenue (USD ) and Growth (2015-2020)

Table Asia-Pacific CAR-T Cell Therapy Sales by Countries (2015-2020)

Table Asia-Pacific CAR-T Cell Therapy Sales Market Share by Countries (2015-2020)

Figure Asia-Pacific CAR-T Cell Therapy Sales Market Share by Countries in 2015

Figure Asia-Pacific CAR-T Cell Therapy Sales Market Share by Countries in 2019

Table Asia-Pacific CAR-T Cell Therapy Revenue (USD ) by Countries (2015-2020)

Table Asia-Pacific CAR-T Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure Asia-Pacific CAR-T Cell Therapy Revenue Market Share by Countries in 2015

Figure Asia-Pacific CAR-T Cell Therapy Revenue Market Share by Countries in 2019

Figure China CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Japan CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure South Korea CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Australia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure India CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Southeast Asia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Middle East and Africa CAR-T Cell Therapy Revenue (USD ) and Growth (2015-2020)

Table Middle East and Africa CAR-T Cell Therapy Sales by Countries (2015-2020)

Table Middle East and Africa CAR-T Cell Therapy Sales Market Share by Countries (2015-2020)

Table Middle East and Africa CAR-T Cell Therapy Revenue (USD ) by Countries (2015-2020)

Table Middle East and Africa CAR-T Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure Middle East and Africa CAR-T Cell Therapy Revenue Market Share by Countries in 2015

Figure Middle East and Africa CAR-T Cell Therapy Revenue Market Share by Countries in 2019

Figure Saudi Arabia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure UAE CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Egypt CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Nigeria CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure South Africa CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure South America CAR-T Cell Therapy Revenue (USD ) and Growth (2015-2020)

Table South America CAR-T Cell Therapy Sales by Countries (2015-2020)

Table South America CAR-T Cell Therapy Sales Market Share by Countries (2015-2020)

Table South America CAR-T Cell Therapy Revenue (USD ) by Countries (2015-2020)

Table South America CAR-T Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure South America CAR-T Cell Therapy Revenue Market Share by Countries in 2015

Figure South America CAR-T Cell Therapy Revenue Market Share by Countries in 2019

Figure Brazil CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Argentina CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Columbia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Chile CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Table Global CAR-T Cell Therapy Sales by Types (2015-2020)

Table Global CAR-T Cell Therapy Sales Share by Types (2015-2020)

Table Global CAR-T Cell Therapy Revenue (USD ) by Types (2015-2020)

Table Global CAR-T Cell Therapy Revenue Share by Types (2015-2020)

Figure Global CD 19 Sales and Growth Rate (2015-2020)

Figure Global CD 19 Price (2015-2020)

Figure Global CD 20 Sales and Growth Rate (2015-2020)

Figure Global CD 20 Price (2015-2020)

Figure Global GD2 Sales and Growth Rate (2015-2020)

Figure Global GD2 Price (2015-2020)

Figure Global CD22 Sales and Growth Rate (2015-2020)

Figure Global CD22 Price (2015-2020)

Figure Global CD30 Sales and Growth Rate (2015-2020)

Figure Global CD30 Price (2015-2020)

Figure Global CD33 Sales and Growth Rate (2015-2020)

Figure Global CD33 Price (2015-2020)

Figure Global HER1 Sales and Growth Rate (2015-2020)

Figure Global HER1 Price (2015-2020)

Figure Global HER2 Sales and Growth Rate (2015-2020)

Figure Global HER2 Price (2015-2020)

Figure Global Meso Sales and Growth Rate (2015-2020)

Figure Global Meso Price (2015-2020)

Figure Global EGFRvlll Sales and Growth Rate (2015-2020)

Figure Global EGFRvlll Price (2015-2020)

Table Global CAR-T Cell Therapy Sales by Applications (2015-2020)

Table Global CAR-T Cell Therapy Sales Share by Applications (2015-2020)

Figure Global Acute Lymphoblastic Leukemia (ALL) Sales and Growth Rate (2015-2020)

Figure Global Acute Lymphoblastic Leukemia (ALL) Revenue and Growth Rate (2015-2020)

Figure Global Chronic lymphocytic leukemia (CLL) Sales and Growth Rate (2015-2020)

Figure Global Chronic lymphocytic leukemia (CLL) Revenue and Growth Rate (2015-2020)

Figure Global Non-Hodgkin lymphoma Sales and Growth Rate (2015-2020)

Figure Global Non-Hodgkin lymphoma Revenue and Growth Rate (2015-2020)

Figure Global Acute myeloid leukemia (AML) Sales and Growth Rate (2015-2020)

Figure Global Acute myeloid leukemia (AML) Revenue and Growth Rate (2015-2020)

Figure Global Neuroblastoma Sales and Growth Rate (2015-2020)

Figure Global Neuroblastoma Revenue and Growth Rate (2015-2020)

Figure Global Multiple myeloma (MM) Sales and Growth Rate (2015-2020)

Figure Global Multiple myeloma (MM) Revenue and Growth Rate (2015-2020)

Figure Global Others Sales and Growth Rate (2015-2020)

Figure Global Others Revenue and Growth Rate (2015-2020)

Figure Global CAR-T Cell Therapy Sales and Growth Rate (2020-2026)

Figure Global CAR-T Cell Therapy Revenue (USD ) and Growth Rate (2020-2026)

Table Global CAR-T Cell Therapy Sales Forecast by Regions (2020-2026)

Table Global CAR-T Cell Therapy Revenue Forecast by Regions (2020-2026)

Figure North America CAR-T Cell Therapy Sales Forecast (2020-2026)

Figure North America CAR-T Cell Therapy Revenue Forecast (2020-2026)

Figure Europe CAR-T Cell Therapy Sales Forecast (2020-2026)

Figure Europe CAR-T Cell Therapy Revenue Forecast (2020-2026)

Figure Asia-Pacific CAR-T Cell Therapy Sales Forecast (2020-2026)

Figure Asia-Pacific CAR-T Cell Therapy Revenue Forecast (2020-2026)

Figure Middle East and Africa CAR-T Cell Therapy Sales Forecast (2020-2026)

Figure Middle East and Africa CAR-T Cell Therapy Revenue Forecast (2020-2026)

Figure South America CAR-T Cell Therapy Sales Forecast (2020-2026)

Figure South America CAR-T Cell Therapy Revenue Forecast (2020-2026)

Table Global CAR-T Cell Therapy Sales Forecast by Types (2020-2026)

Table Global CAR-T Cell Therapy Sales Market Share Forecast by Types (2020-2026)

Table Global CAR-T Cell Therapy Revenue Forecast by Types (2020-2026)

Table Global CAR-T Cell Therapy Revenue Market Share Forecast by Types (2020-2026)

Table Global CAR-T Cell Therapy Sales Forecast by Applications (2020-2026)

Table Global CAR-T Cell Therapy Sales Market Share Forecast by Applications (2020-2026)

Table Global CAR-T Cell Therapy Revenue Forecast by Applications (2020-2026)

Table Global CAR-T Cell Therapy Revenue Market Share Forecast by Applications (2020-2026)

 

Licence Rights

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The CAR-T Cell Therapy market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global CAR-T Cell Therapy market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global CAR-T Cell Therapy market. The report focuses on well-known providers in the global CAR-T Cell Therapy industry, market segments, competition, and the macro environment.
 
Under COVID-19 Outbreak, how the CAR-T Cell Therapy Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
 
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
 
Key players in the global CAR-T Cell Therapy market covered in Chapter 4:
Novartis International AG
Celgene Corporation
Kite Pharma, Inc. (Gilead Sciences, Inc.)
Aurora Biopharma Inc
Mustang Bio, Inc.
Legend Biotech (Genscript Biotech Corporation)
CARsgen Therapeutics, Ltd.
Sorrento Therapeutics Inc.
Pfizer, Inc.
 
In Chapter 11 and 13.3, on the basis of types, the CAR-T Cell Therapy market from 2015 to 2026 is primarily split into:
CD 19
CD 20
GD2
CD22
CD30
CD33
HER1
HER2
Meso
EGFRvlll
 
In Chapter 12 and 13.4, on the basis of applications, the CAR-T Cell Therapy market from 2015 to 2026 covers:
Acute Lymphoblastic Leukemia (ALL)
Chronic lymphocytic leukemia (CLL)
Non-Hodgkin lymphoma
Acute myeloid leukemia (AML)
Neuroblastoma
Multiple myeloma (MM)
Others
 
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
 
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
READ MORE

Scope

Table of Content

 

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global CAR-T Cell Therapy Market Share by Type (2020-2026)

1.5.2 CD 19

1.5.3 CD 20

1.5.4 GD2

1.5.5 CD22

1.5.6 CD30

1.5.7 CD33

1.5.8 HER1

1.5.9 HER2

1.5.10 Meso

1.5.11 EGFRvlll

1.6 Market by Application

1.6.1 Global CAR-T Cell Therapy Market Share by Application (2020-2026)

1.6.2 Acute Lymphoblastic Leukemia (ALL)

1.6.3 Chronic lymphocytic leukemia (CLL)

1.6.4 Non-Hodgkin lymphoma

1.6.5 Acute myeloid leukemia (AML)

1.6.6 Neuroblastoma

1.6.7 Multiple myeloma (MM)

1.6.8 Others

1.7 CAR-T Cell Therapy Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on CAR-T Cell Therapy Industry Development

 

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 PorteraEUR s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

 

3 Value Chain of CAR-T Cell Therapy Market

3.1 Value Chain Status

3.2 CAR-T Cell Therapy Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of CAR-T Cell Therapy

3.2.3 Labor Cost of CAR-T Cell Therapy

3.2.3.1 Labor Cost of CAR-T Cell Therapy Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

 

4 Players Profiles

4.1 Novartis International AG

4.1.1 Novartis International AG Basic Information

4.1.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.1.3 Novartis International AG CAR-T Cell Therapy Market Performance (2015-2020)

4.1.4 Novartis International AG Business Overview

4.2 Celgene Corporation

4.2.1 Celgene Corporation Basic Information

4.2.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.2.3 Celgene Corporation CAR-T Cell Therapy Market Performance (2015-2020)

4.2.4 Celgene Corporation Business Overview

4.3 Kite Pharma, Inc. (Gilead Sciences, Inc.)

4.3.1 Kite Pharma, Inc. (Gilead Sciences, Inc.) Basic Information

4.3.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.3.3 Kite Pharma, Inc. (Gilead Sciences, Inc.) CAR-T Cell Therapy Market Performance (2015-2020)

4.3.4 Kite Pharma, Inc. (Gilead Sciences, Inc.) Business Overview

4.4 Aurora Biopharma Inc

4.4.1 Aurora Biopharma Inc Basic Information

4.4.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.4.3 Aurora Biopharma Inc CAR-T Cell Therapy Market Performance (2015-2020)

4.4.4 Aurora Biopharma Inc Business Overview

4.5 Mustang Bio, Inc.

4.5.1 Mustang Bio, Inc. Basic Information

4.5.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.5.3 Mustang Bio, Inc. CAR-T Cell Therapy Market Performance (2015-2020)

4.5.4 Mustang Bio, Inc. Business Overview

4.6 Legend Biotech (Genscript Biotech Corporation)

4.6.1 Legend Biotech (Genscript Biotech Corporation) Basic Information

4.6.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.6.3 Legend Biotech (Genscript Biotech Corporation) CAR-T Cell Therapy Market Performance (2015-2020)

4.6.4 Legend Biotech (Genscript Biotech Corporation) Business Overview

4.7 CARsgen Therapeutics, Ltd.

4.7.1 CARsgen Therapeutics, Ltd. Basic Information

4.7.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.7.3 CARsgen Therapeutics, Ltd. CAR-T Cell Therapy Market Performance (2015-2020)

4.7.4 CARsgen Therapeutics, Ltd. Business Overview

4.8 Sorrento Therapeutics Inc.

4.8.1 Sorrento Therapeutics Inc. Basic Information

4.8.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.8.3 Sorrento Therapeutics Inc. CAR-T Cell Therapy Market Performance (2015-2020)

4.8.4 Sorrento Therapeutics Inc. Business Overview

4.9 Pfizer, Inc.

4.9.1 Pfizer, Inc. Basic Information

4.9.2 CAR-T Cell Therapy Product Profiles, Application and Specification

4.9.3 Pfizer, Inc. CAR-T Cell Therapy Market Performance (2015-2020)

4.9.4 Pfizer, Inc. Business Overview

 

5 Global CAR-T Cell Therapy Market Analysis by Regions

5.1 Global CAR-T Cell Therapy Sales, Revenue and Market Share by Regions

5.1.1 Global CAR-T Cell Therapy Sales by Regions (2015-2020)

5.1.2 Global CAR-T Cell Therapy Revenue by Regions (2015-2020)

5.2 North America CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

5.3 Europe CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

5.6 South America CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

 

6 North America CAR-T Cell Therapy Market Analysis by Countries

6.1 North America CAR-T Cell Therapy Sales, Revenue and Market Share by Countries

6.1.1 North America CAR-T Cell Therapy Sales by Countries (2015-2020)

6.1.2 North America CAR-T Cell Therapy Revenue by Countries (2015-2020)

6.1.3 North America CAR-T Cell Therapy Market Under COVID-19

6.2 United States CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

6.2.1 United States CAR-T Cell Therapy Market Under COVID-19

6.3 Canada CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

6.4 Mexico CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

 

7 Europe CAR-T Cell Therapy Market Analysis by Countries

7.1 Europe CAR-T Cell Therapy Sales, Revenue and Market Share by Countries

7.1.1 Europe CAR-T Cell Therapy Sales by Countries (2015-2020)

7.1.2 Europe CAR-T Cell Therapy Revenue by Countries (2015-2020)

7.1.3 Europe CAR-T Cell Therapy Market Under COVID-19

7.2 Germany CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

7.2.1 Germany CAR-T Cell Therapy Market Under COVID-19

7.3 UK CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

7.3.1 UK CAR-T Cell Therapy Market Under COVID-19

7.4 France CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

7.4.1 France CAR-T Cell Therapy Market Under COVID-19

7.5 Italy CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

7.5.1 Italy CAR-T Cell Therapy Market Under COVID-19

7.6 Spain CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

7.6.1 Spain CAR-T Cell Therapy Market Under COVID-19

7.7 Russia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

7.7.1 Russia CAR-T Cell Therapy Market Under COVID-19

 

8 Asia-Pacific CAR-T Cell Therapy Market Analysis by Countries

8.1 Asia-Pacific CAR-T Cell Therapy Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific CAR-T Cell Therapy Sales by Countries (2015-2020)

8.1.2 Asia-Pacific CAR-T Cell Therapy Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific CAR-T Cell Therapy Market Under COVID-19

8.2 China CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

8.2.1 China CAR-T Cell Therapy Market Under COVID-19

8.3 Japan CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

8.3.1 Japan CAR-T Cell Therapy Market Under COVID-19

8.4 South Korea CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

8.4.1 South Korea CAR-T Cell Therapy Market Under COVID-19

8.5 Australia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

8.6 India CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

8.6.1 India CAR-T Cell Therapy Market Under COVID-19

8.7 Southeast Asia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia CAR-T Cell Therapy Market Under COVID-19

 

9 Middle East and Africa CAR-T Cell Therapy Market Analysis by Countries

9.1 Middle East and Africa CAR-T Cell Therapy Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa CAR-T Cell Therapy Sales by Countries (2015-2020)

9.1.2 Middle East and Africa CAR-T Cell Therapy Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa CAR-T Cell Therapy Market Under COVID-19

9.2 Saudi Arabia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

9.3 UAE CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

9.4 Egypt CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

9.5 Nigeria CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

9.6 South Africa CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

 

10 South America CAR-T Cell Therapy Market Analysis by Countries

10.1 South America CAR-T Cell Therapy Sales, Revenue and Market Share by Countries

10.1.1 South America CAR-T Cell Therapy Sales by Countries (2015-2020)

10.1.2 South America CAR-T Cell Therapy Revenue by Countries (2015-2020)

10.1.3 South America CAR-T Cell Therapy Market Under COVID-19

10.2 Brazil CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

10.2.1 Brazil CAR-T Cell Therapy Market Under COVID-19

10.3 Argentina CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

10.4 Columbia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

10.5 Chile CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

 

11 Global CAR-T Cell Therapy Market Segment by Types

11.1 Global CAR-T Cell Therapy Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global CAR-T Cell Therapy Sales and Market Share by Types (2015-2020)

11.1.2 Global CAR-T Cell Therapy Revenue and Market Share by Types (2015-2020)

11.2 CD 19 Sales and Price (2015-2020)

11.3 CD 20 Sales and Price (2015-2020)

11.4 GD2 Sales and Price (2015-2020)

11.5 CD22 Sales and Price (2015-2020)

11.6 CD30 Sales and Price (2015-2020)

11.7 CD33 Sales and Price (2015-2020)

11.8 HER1 Sales and Price (2015-2020)

11.9 HER2 Sales and Price (2015-2020)

11.10 Meso Sales and Price (2015-2020)

11.11 EGFRvlll Sales and Price (2015-2020)

 

12 Global CAR-T Cell Therapy Market Segment by Applications

12.1 Global CAR-T Cell Therapy Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global CAR-T Cell Therapy Sales and Market Share by Applications (2015-2020)

12.1.2 Global CAR-T Cell Therapy Revenue and Market Share by Applications (2015-2020)

12.2 Acute Lymphoblastic Leukemia (ALL) Sales, Revenue and Growth Rate (2015-2020)

12.3 Chronic lymphocytic leukemia (CLL) Sales, Revenue and Growth Rate (2015-2020)

12.4 Non-Hodgkin lymphoma Sales, Revenue and Growth Rate (2015-2020)

12.5 Acute myeloid leukemia (AML) Sales, Revenue and Growth Rate (2015-2020)

12.6 Neuroblastoma Sales, Revenue and Growth Rate (2015-2020)

12.7 Multiple myeloma (MM) Sales, Revenue and Growth Rate (2015-2020)

12.8 Others Sales, Revenue and Growth Rate (2015-2020)

 

13 CAR-T Cell Therapy Market Forecast by Regions (2020-2026)

13.1 Global CAR-T Cell Therapy Sales, Revenue and Growth Rate (2020-2026)

13.2 CAR-T Cell Therapy Market Forecast by Regions (2020-2026)

13.2.1 North America CAR-T Cell Therapy Market Forecast (2020-2026)

13.2.2 Europe CAR-T Cell Therapy Market Forecast (2020-2026)

13.2.3 Asia-Pacific CAR-T Cell Therapy Market Forecast (2020-2026)

13.2.4 Middle East and Africa CAR-T Cell Therapy Market Forecast (2020-2026)

13.2.5 South America CAR-T Cell Therapy Market Forecast (2020-2026)

13.3 CAR-T Cell Therapy Market Forecast by Types (2020-2026)

13.4 CAR-T Cell Therapy Market Forecast by Applications (2020-2026)

13.5 CAR-T Cell Therapy Market Forecast Under COVID-19

 

14 Appendix

14.1 Methodology

14.2 Research Data Source

 


List Of Figure

List of Tables and Figures

Table Global CAR-T Cell Therapy Market Size Growth Rate by Type (2020-2026)

Figure Global CAR-T Cell Therapy Market Share by Type in 2019 & 2026

Figure CD 19 Features

Figure CD 20 Features

Figure GD2 Features

Figure CD22 Features

Figure CD30 Features

Figure CD33 Features

Figure HER1 Features

Figure HER2 Features

Figure Meso Features

Figure EGFRvlll Features

Table Global CAR-T Cell Therapy Market Size Growth by Application (2020-2026)

Figure Global CAR-T Cell Therapy Market Share by Application in 2019 & 2026

Figure Acute Lymphoblastic Leukemia (ALL) Description

Figure Chronic lymphocytic leukemia (CLL) Description

Figure Non-Hodgkin lymphoma Description

Figure Acute myeloid leukemia (AML) Description

Figure Neuroblastoma Description

Figure Multiple myeloma (MM) Description

Figure Others Description

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on CAR-T Cell Therapy Industry Development

Table SWOT Analysis

Figure Porter's Five Forces Analysis

Figure Global CAR-T Cell Therapy Market Size and Growth Rate 2015-2026

Table Industry News

Table Industry Policies

Figure Value Chain Status of CAR-T Cell Therapy

Figure Production Process of CAR-T Cell Therapy

Figure Manufacturing Cost Structure of CAR-T Cell Therapy

Figure Major Company Analysis (by Business Distribution Base, by Product Type)

Table Downstream Major Customer Analysis (by Region)

Table Novartis International AG Profile

Table Novartis International AG Production, Value, Price, Gross Margin 2015-2020

Table Celgene Corporation Profile

Table Celgene Corporation Production, Value, Price, Gross Margin 2015-2020

Table Kite Pharma, Inc. (Gilead Sciences, Inc.) Profile

Table Kite Pharma, Inc. (Gilead Sciences, Inc.) Production, Value, Price, Gross Margin 2015-2020

Table Aurora Biopharma Inc Profile

Table Aurora Biopharma Inc Production, Value, Price, Gross Margin 2015-2020

Table Mustang Bio, Inc. Profile

Table Mustang Bio, Inc. Production, Value, Price, Gross Margin 2015-2020

Table Legend Biotech (Genscript Biotech Corporation) Profile

Table Legend Biotech (Genscript Biotech Corporation) Production, Value, Price, Gross Margin 2015-2020

Table CARsgen Therapeutics, Ltd. Profile

Table CARsgen Therapeutics, Ltd. Production, Value, Price, Gross Margin 2015-2020

Table Sorrento Therapeutics Inc. Profile

Table Sorrento Therapeutics Inc. Production, Value, Price, Gross Margin 2015-2020

Table Pfizer, Inc. Profile

Table Pfizer, Inc. Production, Value, Price, Gross Margin 2015-2020

Figure Global CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Global CAR-T Cell Therapy Revenue (USD ) and Growth (2015-2020)

Table Global CAR-T Cell Therapy Sales by Regions (2015-2020)

Table Global CAR-T Cell Therapy Sales Market Share by Regions (2015-2020)

Table Global CAR-T Cell Therapy Revenue (USD ) by Regions (2015-2020)

Table Global CAR-T Cell Therapy Revenue Market Share by Regions (2015-2020)

Table Global CAR-T Cell Therapy Revenue Market Share by Regions in 2015

Table Global CAR-T Cell Therapy Revenue Market Share by Regions in 2019

Figure North America CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Europe CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Asia-Pacific CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Middle East and Africa CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure South America CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure North America CAR-T Cell Therapy Revenue (USD ) and Growth (2015-2020)

Table North America CAR-T Cell Therapy Sales by Countries (2015-2020)

Table North America CAR-T Cell Therapy Sales Market Share by Countries (2015-2020)

Figure North America CAR-T Cell Therapy Sales Market Share by Countries in 2015

Figure North America CAR-T Cell Therapy Sales Market Share by Countries in 2019

Table North America CAR-T Cell Therapy Revenue (USD ) by Countries (2015-2020)

Table North America CAR-T Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure North America CAR-T Cell Therapy Revenue Market Share by Countries in 2015

Figure North America CAR-T Cell Therapy Revenue Market Share by Countries in 2019

Figure United States CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Canada CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Mexico CAR-T Cell Therapy Sales and Growth (2015-2020)

Figure Europe CAR-T Cell Therapy Revenue (USD ) Growth (2015-2020)

Table Europe CAR-T Cell Therapy Sales by Countries (2015-2020)

Table Europe CAR-T Cell Therapy Sales Market Share by Countries (2015-2020)

Figure Europe CAR-T Cell Therapy Sales Market Share by Countries in 2015

Figure Europe CAR-T Cell Therapy Sales Market Share by Countries in 2019

Table Europe CAR-T Cell Therapy Revenue (USD ) by Countries (2015-2020)

Table Europe CAR-T Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure Europe CAR-T Cell Therapy Revenue Market Share by Countries in 2015

Figure Europe CAR-T Cell Therapy Revenue Market Share by Countries in 2019

Figure Germany CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure UK CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure France CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Italy CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Spain CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Russia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Asia-Pacific CAR-T Cell Therapy Revenue (USD ) and Growth (2015-2020)

Table Asia-Pacific CAR-T Cell Therapy Sales by Countries (2015-2020)

Table Asia-Pacific CAR-T Cell Therapy Sales Market Share by Countries (2015-2020)

Figure Asia-Pacific CAR-T Cell Therapy Sales Market Share by Countries in 2015

Figure Asia-Pacific CAR-T Cell Therapy Sales Market Share by Countries in 2019

Table Asia-Pacific CAR-T Cell Therapy Revenue (USD ) by Countries (2015-2020)

Table Asia-Pacific CAR-T Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure Asia-Pacific CAR-T Cell Therapy Revenue Market Share by Countries in 2015

Figure Asia-Pacific CAR-T Cell Therapy Revenue Market Share by Countries in 2019

Figure China CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Japan CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure South Korea CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Australia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure India CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Southeast Asia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Middle East and Africa CAR-T Cell Therapy Revenue (USD ) and Growth (2015-2020)

Table Middle East and Africa CAR-T Cell Therapy Sales by Countries (2015-2020)

Table Middle East and Africa CAR-T Cell Therapy Sales Market Share by Countries (2015-2020)

Table Middle East and Africa CAR-T Cell Therapy Revenue (USD ) by Countries (2015-2020)

Table Middle East and Africa CAR-T Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure Middle East and Africa CAR-T Cell Therapy Revenue Market Share by Countries in 2015

Figure Middle East and Africa CAR-T Cell Therapy Revenue Market Share by Countries in 2019

Figure Saudi Arabia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure UAE CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Egypt CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Nigeria CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure South Africa CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure South America CAR-T Cell Therapy Revenue (USD ) and Growth (2015-2020)

Table South America CAR-T Cell Therapy Sales by Countries (2015-2020)

Table South America CAR-T Cell Therapy Sales Market Share by Countries (2015-2020)

Table South America CAR-T Cell Therapy Revenue (USD ) by Countries (2015-2020)

Table South America CAR-T Cell Therapy Revenue Market Share by Countries (2015-2020)

Figure South America CAR-T Cell Therapy Revenue Market Share by Countries in 2015

Figure South America CAR-T Cell Therapy Revenue Market Share by Countries in 2019

Figure Brazil CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Argentina CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Columbia CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Figure Chile CAR-T Cell Therapy Sales and Growth Rate (2015-2020)

Table Global CAR-T Cell Therapy Sales by Types (2015-2020)

Table Global CAR-T Cell Therapy Sales Share by Types (2015-2020)

Table Global CAR-T Cell Therapy Revenue (USD ) by Types (2015-2020)

Table Global CAR-T Cell Therapy Revenue Share by Types (2015-2020)

Figure Global CD 19 Sales and Growth Rate (2015-2020)

Figure Global CD 19 Price (2015-2020)

Figure Global CD 20 Sales and Growth Rate (2015-2020)

Figure Global CD 20 Price (2015-2020)

Figure Global GD2 Sales and Growth Rate (2015-2020)

Figure Global GD2 Price (2015-2020)

Figure Global CD22 Sales and Growth Rate (2015-2020)

Figure Global CD22 Price (2015-2020)

Figure Global CD30 Sales and Growth Rate (2015-2020)

Figure Global CD30 Price (2015-2020)

Figure Global CD33 Sales and Growth Rate (2015-2020)

Figure Global CD33 Price (2015-2020)

Figure Global HER1 Sales and Growth Rate (2015-2020)

Figure Global HER1 Price (2015-2020)

Figure Global HER2 Sales and Growth Rate (2015-2020)

Figure Global HER2 Price (2015-2020)

Figure Global Meso Sales and Growth Rate (2015-2020)

Figure Global Meso Price (2015-2020)

Figure Global EGFRvlll Sales and Growth Rate (2015-2020)

Figure Global EGFRvlll Price (2015-2020)

Table Global CAR-T Cell Therapy Sales by Applications (2015-2020)

Table Global CAR-T Cell Therapy Sales Share by Applications (2015-2020)

Figure Global Acute Lymphoblastic Leukemia (ALL) Sales and Growth Rate (2015-2020)

Figure Global Acute Lymphoblastic Leukemia (ALL) Revenue and Growth Rate (2015-2020)

Figure Global Chronic lymphocytic leukemia (CLL) Sales and Growth Rate (2015-2020)

Figure Global Chronic lymphocytic leukemia (CLL) Revenue and Growth Rate (2015-2020)

Figure Global Non-Hodgkin lymphoma Sales and Growth Rate (2015-2020)

Figure Global Non-Hodgkin lymphoma Revenue and Growth Rate (2015-2020)

Figure Global Acute myeloid leukemia (AML) Sales and Growth Rate (2015-2020)

Figure Global Acute myeloid leukemia (AML) Revenue and Growth Rate (2015-2020)

Figure Global Neuroblastoma Sales and Growth Rate (2015-2020)

Figure Global Neuroblastoma Revenue and Growth Rate (2015-2020)

Figure Global Multiple myeloma (MM) Sales and Growth Rate (2015-2020)

Figure Global Multiple myeloma (MM) Revenue and Growth Rate (2015-2020)

Figure Global Others Sales and Growth Rate (2015-2020)

Figure Global Others Revenue and Growth Rate (2015-2020)

Figure Global CAR-T Cell Therapy Sales and Growth Rate (2020-2026)

Figure Global CAR-T Cell Therapy Revenue (USD ) and Growth Rate (2020-2026)

Table Global CAR-T Cell Therapy Sales Forecast by Regions (2020-2026)

Table Global CAR-T Cell Therapy Revenue Forecast by Regions (2020-2026)

Figure North America CAR-T Cell Therapy Sales Forecast (2020-2026)

Figure North America CAR-T Cell Therapy Revenue Forecast (2020-2026)

Figure Europe CAR-T Cell Therapy Sales Forecast (2020-2026)

Figure Europe CAR-T Cell Therapy Revenue Forecast (2020-2026)

Figure Asia-Pacific CAR-T Cell Therapy Sales Forecast (2020-2026)

Figure Asia-Pacific CAR-T Cell Therapy Revenue Forecast (2020-2026)

Figure Middle East and Africa CAR-T Cell Therapy Sales Forecast (2020-2026)

Figure Middle East and Africa CAR-T Cell Therapy Revenue Forecast (2020-2026)

Figure South America CAR-T Cell Therapy Sales Forecast (2020-2026)

Figure South America CAR-T Cell Therapy Revenue Forecast (2020-2026)

Table Global CAR-T Cell Therapy Sales Forecast by Types (2020-2026)

Table Global CAR-T Cell Therapy Sales Market Share Forecast by Types (2020-2026)

Table Global CAR-T Cell Therapy Revenue Forecast by Types (2020-2026)

Table Global CAR-T Cell Therapy Revenue Market Share Forecast by Types (2020-2026)

Table Global CAR-T Cell Therapy Sales Forecast by Applications (2020-2026)

Table Global CAR-T Cell Therapy Sales Market Share Forecast by Applications (2020-2026)

Table Global CAR-T Cell Therapy Revenue Forecast by Applications (2020-2026)

Table Global CAR-T Cell Therapy Revenue Market Share Forecast by Applications (2020-2026)

 

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS